Articles from Biotech Business (September 1, 2004)

1-5 out of 5 article(s)

Title	Author	Type	Words
AGENSYS/GENENTECH SIGN COLLABORATION/LICENSE AGREEMENT.			384
ALEXION REACHES AGREEMENT WITH FDA FOR PHASE III ECULIZUMAB.			1087
HYBRIDON'S OLIGONUCLEOTIDES SHOW POTENT ADJUVANT ACTIVITY.			417
POWER3 GETS RIGHTS TO NEURODEGENERATIVE DISEASE BLOOD TEST.			417
SOMALOGIC GETS RIGHTS TO DNA MODIFICATION PATENTS.			279

Publications by Name	Publications by Date	Authors	Literature
A-D E-O P-T U-Z	before 1995 1995-1999 2000-2004 2005-2009 2010-	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z